TrialLeukemia2022
Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial.
Ryan Yen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it